vesnarinone has been researched along with Coronary Disease in 4 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feldman, AM | 1 |
| Baughman, KL | 1 |
| Lee, WK | 1 |
| Gottlieb, SH | 1 |
| Weiss, JL | 1 |
| Becker, LC | 1 |
| Strobeck, JE | 1 |
| Nanto, S | 1 |
| Kodama, K | 2 |
| Kimura, Y | 1 |
| Masuyama, T | 1 |
| Mishima, M | 1 |
| Hamanaka, Y | 1 |
| Hori, M | 3 |
| Inoue, M | 3 |
| Sasayama, S | 1 |
| Asanoi, H | 1 |
| Sakurai, T | 1 |
| Kawai, C | 1 |
| Tamai, J | 1 |
| Koretsune, Y | 1 |
| Kitakaze, M | 1 |
| Iwai, K | 1 |
| Iwakura, K | 1 |
| Kamada, T | 1 |
1 trial available for vesnarinone and Coronary Disease
| Article | Year |
|---|---|
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardioton | 1991 |
3 other studies available for vesnarinone and Coronary Disease
| Article | Year |
|---|---|
Effect of OPC-8212 (2(1H)-quinolinone), a new inotropic agent, on myocardial energy metabolism in patients with coronary heart disease.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Energy Metabolism; Heart; H | 1988 |
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coro | 1986 |
Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxy benzoyl)-1-piperazinyl)-2(1H)-quinolinone on myocardial oxygen consumption in dogs with ischemic heart failure.
Topics: Animals; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Hemodynamics; Oxygen Consumption; Pyr | 1986 |